Biotech of the Week: Synpromics, the Scottish company enabling precise Gene Expression
This week we leave the wonderful weather of Mallorca and head North, through France, England…
November 6, 2015 - 2 minutes
uniQure
UniQure’s cure for rare Lysosomal disease ready for phase III trial
UniQure from the Netherlands has promising results for its enzyme replacement therapy phase Ib/II trial…
September 22, 2015 - 3 minutes
FDA shelves UniQure’s Glybera – will the Gene therapy once reach the US market?
The €1.1M drug Glybera was the first gene therapy on the European market. UniQure wants…
August 28, 2015 - 2 minutes
A Tale of Love for UniQure and Bristol-Myers Squibb
In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure's gene therapy platform…
August 12, 2015 - 2 minutes
GSK sparks off the Gene Therapy resurgence
GlaxoSmithKline has become the first big pharma company to file a gene therapy approval case to the…
May 8, 2015 - 4 minutes
A New Key Strategic Collaboration Between BMS and UniQure
Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at…
April 7, 2015 - 3 minutes
Synpromics and UniQure, new Collaboration in Gene Therapy.
Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to…
March 5, 2015 - 2 minutes
Forbion Capital Partners: a Leading European Biotech VC is rising!
Forbion Capital Partners, the leading Dutch Venture Capital firm investing in world-class healthcare technologies, sold PneumRx of…
December 5, 2014 - 3 minutes
The First Gene Therapy Drug Will Be Sold at Record €1,1M Price
What could you buy with €1,1M euros? A house? Or a single prescription for a new…
December 1, 2014 - 3 minutes
uniQure acquires the gene therapy start-up InoCard
uniQure, a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an…
August 20, 2014 - 3 minutes
